EUVIMEDEUVIMED entdecken
Crossref

Semaglutide in patients with hidradenitis suppurativa and obesity

Joana Nicolau, Pilar Sanchís, Antoni Nadal, María Isabel Tamayo, Guido Sfondrini, Mireia Grimalt, Paula García, Cristina Nadal, Lluís Masmiquel

Medicina Clínica · 2026-05 · 166 (5) · 107405

DOI: 10.1016/j.medcli.2026.107405 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medicina Clínica, 2026-05. Verfasst von Joana Nicolau und 8 weiteren Autor:innen. Beteiligte Einrichtung: Vascular and Metabolic Diseases Research Group, Endocrinology Department, Son Llàtzer University Hospital, Health Research Institute of the Balearic …. Hauptthemen laut MEDLINE: Hidradenitis Suppurativa, Obesity, Glucagon-Like Peptides. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hidradenitis SuppurativaObesityGlucagon-Like PeptidesHumansSemaglutideFemaleMaleAdultProspective StudiesMiddle AgedQuality of LifeTreatment OutcomeWeight Loss

Stichwörter der Autor:innen

DLQIHidradenitis suppurativaHidradenitis supurativaHurleyInflammatory markersObesidadObesityParámetros inflamatoriosSemaglutidaSemaglutide

Substanzen

SemaglutideGlucagon-Like Peptides

Autor:innen und Institutionen

  • Vascular and Metabolic Diseases Research Group, Endocrinology Department, Son Llàtzer University Hospital, Health Research Institute of the Balearic Islands (IdISBa), Palma de Mallorca, Spain; Interdisciplinary Group in…
  • Interdisciplinary Group in Neurodegeneration, Vascular and Metabolic Diseases, University of Balearic Islands (UIB), Health Research Institute of the Balearic Islands (IdISBa), Palma de Mallorca, Spain; CIBER Fisiopatol…
  • Dermatology Department, Son Llàtzer University Hospital, Palma de Mallorca, Spain.
  • Vascular and Metabolic Diseases Research Group, Endocrinology Department, Son Llàtzer University Hospital, Health Research Institute of the Balearic Islands (IdISBa), Palma de Mallorca, Spain.

Zitieren

APA

Nicolau, J., Sanchís, P., Nadal, A., Isabel Tamayo, M., Sfondrini, G., Grimalt, M., García, P., Nadal, C., & Masmiquel, L. (2026). Semaglutide in patients with hidradenitis suppurativa and obesity. Medicina Clínica, 166(5), 107405. https://doi.org/10.1016/j.medcli.2026.107405

Vancouver

Nicolau J, Sanchís P, Nadal A, Isabel Tamayo M, Sfondrini G, Grimalt M, et al. Semaglutide in patients with hidradenitis suppurativa and obesity. Medicina Clínica. 2026;166(5):107405. doi:10.1016/j.medcli.2026.107405

BibTeX
@article{Nicolau2026,
  author = {Nicolau, Joana and Sanchís, Pilar and Nadal, Antoni and Isabel Tamayo, María and Sfondrini, Guido and Grimalt, Mireia and García, Paula and Nadal, Cristina and Masmiquel, Lluís},
  title = {Semaglutide in patients with hidradenitis suppurativa and obesity},
  journal = {Medicina Clínica},
  year = {2026},
  volume = {166},
  number = {5},
  pages = {107405},
  doi = {10.1016/j.medcli.2026.107405}
}
Kostenlos starten →